PAMELA DAMIANI: Open Payments
NPI 1346413416 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 43 payments from 10 companies in 2025. Trend: 2023 $442 · 2024 $509 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $250 |
| ABBVIE INC. | 10 | $156 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Rybelsus, QULIPTA, Wegovy, UBRELVY, AIRSUPRA, The Cologuard Plus Collection Kit, EVENITY, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
